On Air Now

Listen

Listen Live Now » 106.1 FM Lansing, Michigan

Weather

Current Conditions(Holt,MI 48842)

More Weather »
60° Feels Like: 60°
Wind: W 9 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 52°

Tomorrow

PM Thunderstorms 74°

Wed Night

Isolated Thunderstorms 54°

Alerts

Ablynx books success with arthritis drug study

BRUSSELS (Reuters) - Belgian biotech firm Ablynx said a clinical study of its rheumatoid arthritis drug ALX-0061 showed promising results and it was now considering how to further develop the drug, including a partnership deal with a bigger company.

"We are now investigating the various possibilities through which we can progress the development of ALX-0061, including discussions with potential partners and other paths which will allow us to maximise the value of this asset," Chief Executive Edwin Moses said in a statement on Wednesday.

Ablynx had carried out the study on 37 patients over the course of 24 weeks and said the drug was well-tolerated and showed positive results.

(Reporting by Robert-Jan Bartunek; editing by Philip Blenkinsop)

Comments